Synribo Chemotherapy Information

When used for treating a type of cancer called chronic myeloid leukemia, SynriboTM (omacetaxine mepesuccinate) works to slow down the progression of the disease by preventing abnormal cells from growing. This prescription chemotherapy drug is specifically approved for use in adults, and is reserved for use after at least two other types of treatment were unable to adequately control the cancer.
 
Although Synribo may help in chemotherapy treatment, not everyone can use this medication. Information on Synribo should be discussed with your healthcare provider before using it to minimize your risk for certain complications. For instance, people who have diabetes or who are taking certain medications may not be able to use this medicine.
 
Synribo is given as an injection just under the skin twice a day for 7 to14 days, every 28 days. Most people who receive this medicine will develop some type of side effect, such as diarrhea, fatigue, and anemia.
 
(Click Synribo for more information on this chemotherapy drug, including how it works, specific uses, and dosing tips on when and how it is administered.)
 
 

Synribo Chemotherapy Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.